Mico BioMed Co. Ltd. Financial Flexibility Index
Mico BioMed Co. Ltd. financial flexibility index. Mico BioMed Co. Ltd. (214610) has a Financial Flexibility Index of -1.03x as of September 2025. Free cash flow of ₩-8.13 Billion (operating CF ₩-8.13 Billion minus capex ₩0.00) represents -1% of total liabilities (₩7.88 Billion). See free cash flow generation of Mico BioMed Co. Ltd. to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Mico BioMed Co. Ltd. (2016–2024)
Financial flexibility index of Mico BioMed Co. Ltd. from 2016 to 2024. Historical Financial Flexibility Index trend for Mico BioMed Co. Ltd. across 9 annual periods. Check 214610 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Mico BioMed Co. Ltd. Financial Flexibility Index by Year (2016–2024)
Mico BioMed Co. Ltd. financial flexibility index by year from 2016 to 2024. Year-by-year free cash flow to debt coverage for Mico BioMed Co. Ltd.. For the full cash flow conversion analysis, see 214610 cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.34x | ₩-9.71 Billion | ₩-10.70 Billion | ₩28.58 Billion | ▲ +20.5% |
| 2023 | -0.43x | ₩-10.68 Billion | ₩-11.36 Billion | ₩24.99 Billion | ▼ -37.4% |
| 2022 | -0.31x | ₩-12.38 Billion | ₩-14.01 Billion | ₩39.82 Billion | ▼ -96.6% |
| 2021 | -0.16x | ₩-5.76 Billion | ₩-8.60 Billion | ₩36.42 Billion | ▲ +81.6% |
| 2020 | -0.86x | ₩-12.92 Billion | ₩-18.68 Billion | ₩15.00 Billion | ▼ -127.4% |
| 2019 | -0.38x | ₩-9.10 Billion | ₩-10.43 Billion | ₩24.01 Billion | ▼ -41.7% |
| 2018 | -0.27x | ₩-4.93 Billion | ₩-6.79 Billion | ₩18.45 Billion | ▼ -43.0% |
| 2017 | -0.19x | ₩-2.43 Billion | ₩-2.89 Billion | ₩13.02 Billion | ▲ +72.1% |
| 2016 | -0.67x | ₩-3.79 Billion | ₩-3.99 Billion | ₩5.65 Billion | — |